HomeEndocrinology
Endocrinology
About 25% of men with testosterone issues delay treatment – UK study
A survey of 2 000 men has found that nearly almost a quarter of those with low testosterone levels struggle with symptoms – and...
SA plan to boost TB testing
A plan to escalate the TB fight by boosting the number of people testing for the disease to 5m over the next 12 months...
Waist-to-height ratio better than BMI to ID childhood obesity, study finds
A collaboration between Finnish and British researchers found that body mass index (BMI) was almost three times more likely to classify children as overweight...
Weight loss of 20%-30% can reverse type 2 diabetes – Qatar analysis
The more weight lost by people with type 2 diabetes, the greater the odds that the disease will go partially or even completely into...
Inaccurate blood sugar monitors could harm non-diabetics – British study
Popular glucose monitors used to take regular blood sugar readings could be driving poor diets and food restrictions because of inaccurate measurements, according to a recent study.
Continuous...
FDA green-lights rapid-acting insulin biosimilar product
The US Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for the improvement of glycaemic control...
SA veering off course in diabetes management
Roughly 60 000 South Africans die annually – before they turn 70 – from diseases that are not caused by an infection like tuberculosis...
Half of diabetics lack essential vitamins – Indian meta-analysis
A recent study has revealed that nearly half of all patients with type 2 diabetes (T2D) experience micronutrient deficiencies, with women experiencing these deficiencies...
Actress' ‘moon face’ linked to steroid disorder
Long-term use of steroidal medicine can lead to a little known, rare condition called Cushing’s syndrome, experts have warned, after an American actress/comedian was...
Major US review maps effectiveness of GLP-1 drugs
A study by the United States Department of Veterans Affairs on the relationship between GLP-1 weight-loss drugs and 175 diseases and conditions supports a...
Obesity measure must go beyond BMI, suggest global experts
A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index...
Blockbuster diabetic drug now in SA
Aspen Pharmacare has announced the local availability of Eli Lilly’s tirzepatide, marketed globally as Mounjaro.
Mounjaro, the once-weekly glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1...
NHS trials AI tool to predict diabetes risk
England’s NHS is launching a world-first trial of a transformative artificial intelligence (AI) tool that can identify patients at risk of type 2 diabetes...
South Africa shoulders high health burden of sugary drinks
A global analysis has placed South Africa among the countries worst hit by the health burden of high consumption of sugary drinks which, together...
Danish studies flag rare optic nerve damage with Ozempic
Scientists involved in two large studies suggest their findings confirm that diabetes medication Ozempic doubles the risk of developing non-arteritic anterior ischaemic optic neuropathy...
Chocolate comparison weighs up type 2 diabetes risks – Harvard-led study
Eating at least five tiny servings of dark chocolate each week may lower the risk of developing type 2 diabetes by 21%, according to...
Revisiting new vitamin D guidelines
An expert who helped craft guidelines for vitamin D supplementation more than a decade ago, reviews the updated guidance published last year by the...
Common thyroid medicine linked to bone loss
Levothyroxine, a drug used to treat hypothyroidism, can lead to reduced bone mass and density in older adults with normal thyroid levels, a small...
SA facing diabetes ‘pandemic’ as cases soar among young people
A critical shortage of specialists to treat diabetics is contributing to the treatment challenges for patients in South Africa where the disease is now...
Babies' reduced sugar intake leads to lower later chronic disease risk – UK study
Children whose sugar consumption was restricted during their first 1 000 days after conception had up to 35% less chance of developing type 2...
Bariatric surgery benefits confirmed in 10-year follow-up study
Ten years after undergoing bariatric surgery as teens, more than half of study participants demonstrated not only sustained weight loss, but also resolution of...
Doctors reminded to flag side effects of GLP-1 agonists
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) is reminding healthcare professionals to ensure patients are aware of the known side effects of glucagon-like...
Metformin for fathers not linked to birth defects – joint study
A large study, which tracked 3m pregnancies in Norway and Taiwan, found that men can take the commonly prescribed diabetes drug metformin without worrying...
GLP-1 drugs may protect brain health – US review
Drugs like Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that go beyond weight loss in people with type 2 diabetes or...
World first as woman’s own stem cells reverse her diabetes
A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells,...
Liraglutide reduces six-year-olds’ weight in nine-country study
Researchers say that liraglutide (Saxenda), in combination with lifestyle intervention, helped reduce the body mass index (BMI) in obese children as young as six.
In...
Insulin, metformin combo helps heal diabetic foot ulcers – US study
People with chronic diabetic foot ulcers could soon have a new way to treat their wounds for faster healing and fewer hospital stays, according...
Zepbound slashes diabetes risk by 94% – Eli Lilly
Tirzepatide, the active ingredient in the popular weight loss medication, Zepbound, has been shown to reduce the risk of developing type 2 diabetes in...
Questions remain on weight loss drugs' suicide risk – US study
A recent study of an international drug safety database – suggesting people taking semaglutide are likelier to think about suicide than those taking other...
Warning after six-month-old babies put on diets
An Australian obesity expert has slammed the current fixation with “ideal” weight ranges, which he warns is driving poor advice that includes putting children...
SA’s diabetes crisis needs urgent response
According to the recently released Diabetes Summit report, around 4.2m South Africans are estimated to be diabetic, while Percept, a Cape Town-based consulting firm,...
Low-calorie sweetener raises blood clot risk – US study
A small study has found that the sugar substitute, erythritol, makes blood more susceptible to clotting, and may explain why it has been linked...
What's behind the shift to earlier puberty?
The jury is still out on just why young people are experiencing puberty earlier than ever, and experts are now calling for a better...
UK approves weight-loss jab for heart attacks, stroke
British health officials have approved weight-loss drug Wegovy to be used to prevent heart attacks and strokes in overweight people, the first such medication...
New review highlighs diabetes research, treatment advances
In a paper surveying advances in diabetes pathogenesis and treatment, and which explores the complex factors contributing to the onset and progression of the...
Experts warn against over-prescription of testosterone for women
The prescribing of testosterone for middle-aged women is “out of control” and may have long-term implications for their health, warn experts, amid concerns over...
Dental trial with generic drug to test anti-ageing efficacy
A drug that was first approved by the FDA for use in transplant patients in the late 1990s is being prescribed off-label by some physicians with...
Nordisk slams study linking rare blindness to semaglutide
Novo Nordisk has criticised as insufficient a recent study suggesting that people using Ozempic or Wegovy for treating obesity or type 2 diabetes may...
Time to rethink how we treat obesity
Although the tide of therapies targeting glucagon-like peptide receptor agonists (GLP-1 RA) – like semaglutide, and di- and triagonists, like tirzepatide and retatrutide –...
Cheaper obesity drugs in Indian and Chinese pipelines
As the patents on various weight-loss drugs near expiry, Indian and Chinese companies are racing to produce biosimilar versions, in efforts to widen affordable...